Diagnosing neuroleukemiosis: Is there a role for 18 F-FDG-PET/CT?
| Autor: | Montserrat Cortés-Romera, Aida Sabaté-Llobera, J.J. Sánchez-Fernández, Laura Rodriguez-Bel, Cristina Gámez-Cenzano, E. Gamundí-Grimalt |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Pathology Nerve root business.industry Complete remission General Engineering Myeloid leukemia Disease medicine.disease 03 medical and health sciences Leukemia 0302 clinical medicine Cerebrospinal fluid hemic and lymphatic diseases medicine Hypermetabolism General Earth and Planetary Sciences Radiology Nuclear Medicine and imaging Fdg pet ct Radiology business 030217 neurology & neurosurgery 030215 immunology General Environmental Science |
| Zdroj: | Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 36:396-398 |
| ISSN: | 2253-8089 |
| DOI: | 10.1016/j.remnie.2017.09.009 |
| Popis: | An imaging case is presented on a patient referred to our department for an 18F-FDG-PET/CT, as a paraneoplastic syndrome was suspected due to his clinical situation. He had a history of acute myeloid leukemia (AML) treated two years earlier, with sustained complete remission to date. 18F-FDG-PET/CT findings revealed hypermetabolism in almost all nerve roots, suggesting meningeal spread, consistent with the subsequent MRI findings. Cerebrospinal fluid (CSF) findings confirmed a leptomeningeal reactivation of AML. Although not many studies have evaluated the role of 18F-FDG-PET/CT in leukemia, it is a noninvasive tool for detecting extramedullary sites of disease and a good imaging alternative for those patients on whom an MRI cannot be performed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect